Niche Market Target fertility clinics and obstetrics practices with a gender selection and early pregnancy testing value proposition, highlighting a claimed high accuracy and patent-backed technology to differentiate from traditional IVF and existing services.

Regulatory & IP Leverage US and international patents to approach partners and investors, emphasizing defensible technology and a potential moat around gender-specific conception methods and early diagnostic capabilities.

Technology Stack Position the firm as a modernized service through a cloud-enabled ecommerce and analytics approach (Cloudflare, WooCommerce, Google Tag Manager) to enable streamlined client onboarding, booking, and performance tracking for partner clinics.

Founders & Focus Highlight leadership emphasis on women's role in gender formation and the science behind cycle-based conception to engage clinical researchers, women's health advocates, and reproductive endocrinology networks for strategic partnerships.

Proof of Value Frame the approximate 80% success rate as a compelling differentiator against IVF, and propose pilot programs or clinic collaborations to demonstrate cost-efficiency and consumer demand to drive adoption and referrals.